This is a Prospective Observational Study Assessing the Variation of Impedance Across the Different Tissues to Locate and Block Nerves When Preforming an Axillary Peripheral Nerve Block. the Results Would Enhance Precision of Needle Placement and Increase the Success Rate of the Block.
Launched by LEBANESE AMERICAN UNIVERSITY · Sep 28, 2024
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different types of body tissues, like skin and muscle, resist electrical flow (a property called impedance) to improve the accuracy of a specific medical procedure called an axillary nerve block. This procedure is often used to manage pain during surgeries on the arm. By understanding how impedance varies in different tissues, the researchers hope to help doctors place the needle more precisely, which could lead to better pain control and fewer complications.
To participate in this study, individuals must be between 18 and 90 years old and should not have any infections where the needle will be inserted. They should also be able to communicate well and not have any serious health issues that could complicate the procedure. Participants can expect to have their impedance measured during the nerve block procedure, and this research might ultimately help improve patient care in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Individuals aged 18 years to 90 years old
- • No infection at the injection site
- • Patient signed the study consent form
- • No contraindications for nerve block
- • No allergies to any of the drugs used
- • Patient able to communicate effectively
- Exclusion Criteria:
- • Patients not meeting the inclusion criteria
- • Patients with bleeding disorders or undergoing anticoagulation therapy
- • Pregnant patients
- • Patients with mental incapacity
- • Any medical conditions posing severe risks during the procedure
About Lebanese American University
The Lebanese American University (LAU) is a distinguished institution dedicated to advancing education and research in the health sciences and related fields. With a strong commitment to excellence, LAU engages in innovative clinical trials aimed at enhancing medical knowledge and improving patient outcomes. The university fosters a collaborative environment that brings together experts from various disciplines to conduct rigorous research, ensuring adherence to ethical standards and regulatory compliance. Through its clinical trials, LAU contributes to the global body of medical research while training the next generation of healthcare professionals.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beirut, , Lebanon
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported